证券维权
Search documents
元道通信2025年净利预计减少,曾被立案索赔已开启
Xin Lang Cai Jing· 2026-01-29 07:33
登录新浪财经APP 搜索【信披】查看更多考评等级 受损股民可至新浪股民维权平台登记该公司维权:http://wq.finance.sina.com.cn/ 关注@新浪证券、微信关注新浪券商基金、百度搜索新浪股民维权、访问新浪财经客户端、 新浪财经首页都能找到我 一、公司披露年度业绩 1月28日晚,元道通信在披露立案进展公告,公司表示若后续经中国证监会行政处罚认定的事实,触及 《深圳证券交易所创业板股票上市规则(2025年修订)》规定的重大违法强制退市情形,公司股票将被 实施重大违法强制退市。 在此需提醒投资者的是该公司财报存疑且被立案调查,如仍交易,即便后续虚假陈述被查实,也可能因 为投资决定与虚假陈述之间的交易因果关系不成立,而无法获得索赔。 信息披露的准确性对于投资者决策和市场公平性至关重要,上市公司的年报或财报对投资者决策意义重 大。受损投资者可查看是否符合上诉条件,决定是否参与维权。 (本文由上海沪紫律师事务所刘鹏律师供稿,不代表新浪财经的观点。刘鹏律师,专注证券维权19年, 自2006年执业以来,成功为中青宝、国华网安、劲嘉股份(维权)等 300 余家上市公司的中小投资者成 功维权,案件在办数量超过 ...
卓朗科技索赔持续征集,已有获赔还可加入!
Xin Lang Cai Jing· 2026-01-28 08:22
Core Viewpoint - The company has faced significant legal challenges due to severe violations leading to its forced delisting, but investors still retain the right to seek compensation through legal channels [1][2][3]. Group 1: Legal Proceedings and Investor Rights - Recent court rulings have favored investors, with the first instance of a victory being reported, indicating that the delisting does not affect the right to claim compensation [1][2]. - The company was forced to delist on March 6, 2023, being the first to face such action under new regulations for major violations [1][2]. - Investors who purchased shares between September 19, 2019, and March 14, 2024, and sold or still hold shares after March 15, 2024, are eligible to join the compensation claims [3][4]. Group 2: Financial Misconduct Details - The company was found to have engaged in fraudulent activities, including fabricating sales related to servers, software, and system integration services, which inflated its reported revenues and profits [3]. - The total amount of falsely reported revenue for 2021 and 2022 reached 995 million yuan, accounting for 57.85% of the total reported revenue for those years [3]. - The total amount of falsely reported profits for the same period was 696 million yuan, representing 56.31% of the total reported profits [3]. Group 3: Legal Expertise and Support - Investors are encouraged to take action through legal means to recover their losses, with the support of experienced legal professionals specializing in securities claims [4]. - The lawyer involved has a strong track record, having successfully represented over 300 companies and handled more than 14,000 cases with a win rate of 99.2% [4].
ST富润退市不影响维权权利,索赔时效告急需尽快加入
Xin Lang Cai Jing· 2026-01-27 07:21
Core Viewpoint - The company *ST Furun has been delisted due to its stock price falling below 1 yuan for twenty consecutive trading days, with the delisting effective on April 30, 2025. Investors who suffered losses during a specific period are encouraged to join the legal claims process against the company for false statements [1][4]. Group 1: Legal Proceedings - A batch of cases has been submitted to the court for the lawsuit against *ST Furun for false statements, with previous successful verdicts in similar cases [1][4]. - Investors who purchased shares between April 27, 2021, and April 27, 2023, and sold or still hold them after April 28, 2023, are advised to join the legal claims [2][4]. Group 2: Financial Misconduct - The company received an administrative penalty from the Zhejiang Regulatory Bureau of the China Securities Regulatory Commission on May 18, 2024, revealing its financial misconduct [2][4]. - From January 2020 to mid-2022, the company's wholly-owned subsidiary engaged in fictitious advertising agency processes, inflating revenue and costs, leading to false records in its annual reports for 2020, 2021, and the semi-annual report for 2022 [2][4]. - The company corrected its financial data on April 28, 2023, following the discovery of accounting errors, and has faced penalties for these false disclosures [2][4].
赛隆药业拟转让子公司股权,曾因修正业绩收警示函
Xin Lang Cai Jing· 2026-01-27 07:21
登录新浪财经APP 搜索【信披】查看更多考评等级 受损股民可至新浪股民维权平台登记该公司维权:http://wq.finance.sina.com.cn/ 关注@新浪证券、微信关注新浪券商基金、百度搜索新浪股民维权、访问新浪财经客户端、 新浪财经首页都能找到我 一、拟转让子公司股权 1月22日,*ST赛隆(维权)发布公告,公司拟公开挂牌转让全资子公司湖南赛隆生物制药有限公司 100%股权。 公司于2025年12月23日召开董事会,通过了相关交易方案,并委托湖南省联合产权交易所进行挂牌转 让。首次挂牌底价根据评估结果确定为8695万元,挂牌公告的起止日期为2026年1月23日至2026年2月12 日。 而公司在年中曾收到广东证监局警示函,主要原因为披露的年报与预告差异较大,且盈亏性质改变。受 此事影响,公司股价下跌,造成不少投资者无端亏损。符合于2025年1月22日-2025年3月14日(含当 日)期间买入,并在2025年3月15日之后卖出或仍持有而亏损的可报名索赔。(赛隆药业维权入口) 登录新浪财经APP 搜索【信披】查看更多考评等级 受损股民可至新浪股民维权平台登记该公司维权:http://wq.finan ...
向日葵被立案持续发酵,交易终止追索4000万意向金
Xin Lang Cai Jing· 2026-01-27 07:21
Group 1 - The investigation into Xiangrikui has led to the termination of its restructuring plan, as the company received a notice from the Zhejiang Securities Regulatory Bureau indicating it does not meet the conditions for issuing shares to purchase assets [1][6] - The company had intended to acquire 100% of Zhangzhou Xipu Materials Technology Co., Ltd. to enter the high-end semiconductor materials sector, but this plan has now fallen through [6] - Xiangrikui paid a deposit of 40 million yuan to Shanghai Xipu in September 2025, and upon termination of the transaction, the deposit is to be refunded within five working days [6] Group 2 - Shanghai Xipu published articles denying allegations made by media regarding its operational status, admitting to making several mistakes during interactions with investors [2][7] - The media reported that one of Xipu's core assets, Jiangsu Fumait, has been out of production for nearly three years and its safety production license has expired, despite being listed as an important asset in the restructuring proposal [7] - Xipu's response to the media included questioning the validity of the reports and asserting that the media's characterization was unjust [7] Group 3 - The stock price of Xiangrikui dropped significantly following the announcement of the investigation, with a 10% decline on the first day, followed by a 20% limit down on the second day, and a further drop of 17.94% on the third day [4][10] - The decline in stock price has resulted in substantial losses for investors, prompting a wave of claims for compensation [10] - Approximately 130,000 shareholders are currently involved in the compensation claims process, with eligibility for claims defined for shares purchased between September 22, 2025, and December 25, 2025 [10]
虚增数百亿,退市仍被罚!东旭光电索赔持续征集中
Xin Lang Cai Jing· 2026-01-26 07:36
Group 1 - The core issue revolves around severe financial fraud by Dongxu Optoelectronics and its parent company, Dongxu Group, leading to a total of 645.85 billion yuan in inflated revenue and a fine of 1.7 billion yuan, affecting over 100,000 investors [1][5] - Regulatory authorities have confirmed that from 2015 to 2019, Dongxu Group inflated its revenue by 478.25 billion yuan and profits by 130.01 billion yuan, while Dongxu Optoelectronics inflated its revenue by 167.6 billion yuan and profits by 56.27 billion yuan [1][5] - The fraudulent activities included illegal fundraising of 75.65 billion yuan in 2017 and 3.5 billion yuan in corporate bonds in 2018 [1][5] Group 2 - Despite the delisting of Dongxu Optoelectronics, investors are still eligible to claim compensation under the Securities Law of the People's Republic of China, which holds information disclosers accountable for losses caused by false information [2][6] - Investors who purchased shares between February 15, 2016, and July 5, 2024, and sold or still hold shares with losses after September 7, 2024, can register for compensation, as the statute of limitations has not yet expired [4][7] - The ongoing issue of financial fraud in the capital market not only harms investor interests but also undermines market fairness and transparency, with eligible investors entitled to claim losses, including differences in investment, commission, stamp duty losses, and corresponding interest [4][7]
二审!股民索赔案件中青宝(300052)公司上诉,未起诉股民仍可参与证券维权
Xin Lang Cai Jing· 2026-01-26 03:59
Core Viewpoint - The recent developments in the lawsuit against Shenzhen Zhongqingbao Interactive Network Co., Ltd. (referred to as "Zhongqingbao") indicate that the company has been found liable for securities fraud, with a first-instance court ruling in favor of the investors, leading to an appeal by the company and the case proceeding to the second instance [1][2][4]. Summary by Relevant Sections Legal Proceedings - Investors represented by lawyer Zhao Jingguo have won a first-instance ruling in a securities fraud case against Zhongqingbao, with the company appealing the decision, thus moving the case to the second instance [1][2]. - The case remains within the statute of limitations, allowing other affected investors to register for compensation [1][2]. Compensation Eligibility - Investors who purchased shares between March 27, 2020, and April 26, 2023, and held them, regardless of whether they sold after April 27, 2023, are eligible for compensation [3][4]. - Additionally, investors who bought shares between April 23, 2024, and July 28, 2024, and held them, regardless of whether they sold after July 29, 2024, may also register for compensation [3][4]. Regulatory Actions - On August 9, 2024, Zhongqingbao announced that it and its actual controller, Zhang Yunxia, received a notice from the China Securities Regulatory Commission (CSRC) regarding an investigation into violations of information disclosure laws [4]. - The CSRC decided to initiate a case against Zhongqingbao and Zhang Yunxia based on findings of false records in annual reports from 2019 to 2021 and failure to timely disclose criminal coercive measures taken against the actual controller [4].
向日葵终止重组半导体资产,已被监管立案索赔征集中
Xin Lang Cai Jing· 2026-01-26 02:01
Group 1 - The company announced the termination of its semiconductor acquisition deal with Shanghai Xipu Technology Co., Ltd, after paying a deposit of 40 million yuan [1][3] - Following the termination, the company requested the return of the deposit, which should be refunded within five working days according to the agreement [1][3] - The company is exploring options for a phased repayment or other feasible arrangements with Shanghai Xipu [1][3] Group 2 - The company is under investigation by the Securities Regulatory Commission for misleading statements in its restructuring proposal [2][4] - A media report revealed that a key asset, Jiangsu Fumait, had been out of production for nearly three years and its safety production license had expired, contradicting the company's claims in the restructuring proposal [2][4] - The misleading statements do not require the information to be entirely false; any presentation that could mislead investors is considered illegal [2][4]
ST宁科成功撤销退市风险,索赔已有获赔案例
Xin Lang Cai Jing· 2026-01-26 02:01
Group 1 - The company *ST Ningke has announced the termination of its restructuring process by the court, leading to the removal of the delisting risk warning for its stock [1][4] - The stock will resume trading on January 14, 2026, under the new name "ST Ningke" after the delisting risk warning is lifted [1][4] - Investors who purchased shares during specific periods and suffered losses are eligible to join the compensation claims [4][6] Group 2 - In 2022, the company inflated its operating revenue by 76.5941 million yuan and its total profit by 77.222 million yuan, representing 11.25% and 46.59% of the respective totals [4] - The company failed to timely disclose significant events, including major debts and the suspension of its subsidiary's main business [4][5] - Investors must meet specific criteria to qualify for compensation, including purchasing shares after the company's false statements and holding them until the statements were revealed [5][6]
新亚制程成功摘帽,这些投资者可加入诉讼
Xin Lang Cai Jing· 2026-01-26 02:01
Core Viewpoint - Xin Ya Zhi Cheng has been penalized for information disclosure violations, leading to a significant legal situation for investors seeking compensation [1][3]. Group 1: Penalties and Violations - Xin Ya Zhi Cheng resumed trading on January 13, 2026, and changed its stock name from "ST Xin Ya" to "Xin Ya Zhi Cheng," becoming the first A-share company to remove its risk warning in 2026 [1][3]. - The company received an administrative penalty from the China Securities Regulatory Commission (CSRC) on December 31, 2024, for non-operational fund occupation and inflated profit reports, resulting in a total fine of 6 million yuan [1][3]. - Investors are advised to prepare relevant trading documents, such as transaction records and account statements, to facilitate the legal team's review for compensation eligibility [1][3]. Group 2: Investor Rights and Compensation - The company had undisclosed fund occupation issues in 2022 and 2023, amounting to 266 million yuan and 271 million yuan, which represented 18.51% and 18.85% of the latest audited net assets, respectively [2][4]. - Inaccurate provisions for bad debts in accounts receivable led to inflated profit totals of 18.67 million yuan and 8.58 million yuan in the 2022 annual report and 2023 semi-annual report, accounting for 30.83% and 50.54% of the respective profit totals [2][4]. - The compensation period for affected investors is set from April 28, 2023, to January 10, 2024, allowing those who bought shares during this timeframe and incurred losses to apply for compensation [5].